DAVID POPLACK to Pilot Projects
This is a "connection" page, showing publications DAVID POPLACK has written about Pilot Projects.
Connection Strength
0.013
-
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma. 2006 Dec; 47(12):2488-504.
Score: 0.013